• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[无可用内容]

[Not Available].

作者信息

Ageev F T, Ovchinnikov A G

机构信息

FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation.

出版信息

Kardiologiia. 2018 Dec 25;58(12S):4-10. doi: 10.18087/cardio.2609.

DOI:10.18087/cardio.2609
PMID:30625103
Abstract

The article discusses the clinical expedience of isolating into a separate classification subgroup of patients with heart failure and a mid‑range ejection fraction (EF) of 40-49 %. Analysis of studies 2017-2018 focusing on the issue of patients with mid‑range LV EF showed that this subgroup is highly heterogenous and by some clinical and demographic parameters takes an intermediate position between heart failure (HF) patients with reduced (<40 %) and preserved (>50 %) LV EF. However, patients with mid‑range LV EF positively respond to beta‑blocker and RAAS inhibitor therapy, and their response is close to that of patients with reduced LV EF. This is a principal difference between patients with mid‑range and preserved LV EF who generally do not display any beneficial effect of such therapy. One of the major causes for such difference is a dissimilarity of HF etiology and, hence, pathogenesis in patients with reduced and mid‑range LV EF: primarily IHD (so‑called "ischemic" phenotype) in patients with reduced and mid‑range LV EF and non‑cardiac causes ("non‑ischemic" phenotype) in patients with preserved LV EF. Since the nonischemic phenotype is also rather common among patients with mid‑range LV EF a new HF classification should definitely indicate, in addition to LV EF, the clinical phenotype of disease, which is particularly important for patients with mid‑range LV EF of 40-49 %. Further studies should focus on variants of HF clinical phenotypes.

摘要

本文讨论了将射血分数(EF)处于40%-49%的心力衰竭患者单独划分到一个分类亚组中的临床便利性。对2017 - 2018年关于中度左室射血分数患者问题的研究分析表明,该亚组具有高度异质性,并且在一些临床和人口统计学参数方面处于左室射血分数降低(<40%)和保留(>50%)的心力衰竭患者之间的中间位置。然而,中度左室射血分数患者对β受体阻滞剂和肾素 - 血管紧张素系统(RAAS)抑制剂治疗有积极反应,且他们的反应与左室射血分数降低的患者相近。这是中度左室射血分数患者与左室射血分数保留患者之间的主要区别,后者通常未显示出此类治疗的任何有益效果。造成这种差异的主要原因之一是左室射血分数降低和中度患者心力衰竭病因及发病机制的不同:左室射血分数降低和中度患者主要为缺血性心脏病(所谓的“缺血性”表型),而左室射血分数保留患者为非心脏病因(“非缺血性”表型)。由于非缺血性表型在中度左室射血分数患者中也相当常见,除左室射血分数外,新的心力衰竭分类肯定应指明疾病的临床表型,这对射血分数为40%-49%的中度左室射血分数患者尤为重要。进一步的研究应聚焦于心力衰竭临床表型的变体。

相似文献

1
[Not Available].[无可用内容]
Kardiologiia. 2018 Dec 25;58(12S):4-10. doi: 10.18087/cardio.2609.
2
Effect of 24-hour blood pressure and heart rate on the prognosis of patients with reduced and midrange LVEF.24 小时血压和心率对左心室射血分数降低和中值的患者预后的影响。
Kardiologiia. 2021 Jul 31;61(7):4-13. doi: 10.18087/cardio.2021.7.n1684.
3
Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.射血分数保留、中等范围和降低的心力衰竭患者中缺血性心脏病的意义:一项全国性队列研究
Circ Heart Fail. 2017 Jun;10(6). doi: 10.1161/CIRCHEARTFAILURE.117.003875.
4
The effect of angiotensin-converting enzyme inhibitors on clinical outcomes in patients with ischemic cardiomyopathy and midrange ejection fraction: a post hoc subgroup analysis from the PEACE trial.血管紧张素转换酶抑制剂对缺血性心肌病和中等射血分数患者临床结局的影响:PEACE试验的事后亚组分析
Ther Adv Cardiovasc Dis. 2018 Dec;12(12):351-359. doi: 10.1177/1753944718809266. Epub 2018 Nov 15.
5
Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.运动对射血分数保留型心力衰竭与射血分数降低型心力衰竭患者左心室收缩和舒张功能的影响。
Circ Heart Fail. 2013 May;6(3):508-16. doi: 10.1161/CIRCHEARTFAILURE.112.000216. Epub 2013 Mar 20.
6
Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.心力衰竭与中等射血分数:射血分数恢复对运动耐量和预后的影响
Circ Heart Fail. 2016 Apr;9(4):e002826. doi: 10.1161/CIRCHEARTFAILURE.115.002826.
7
Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure.新型非缺血性心力衰竭相关活性氧化代谢物的影响。
J Am Heart Assoc. 2021 Apr 6;10(7):e016765. doi: 10.1161/JAHA.120.016765. Epub 2021 Mar 18.
8
Accuracy of tissue Doppler echocardiography in the diagnosis of new-onset congestive heart failure in patients with levels of B-type natriuretic peptide in the midrange and normal left ventricular ejection fraction.组织多普勒超声心动图在诊断B型利钠肽水平处于中等范围且左心室射血分数正常的新发充血性心力衰竭患者中的准确性。
Echocardiography. 2006 Sep;23(8):627-34. doi: 10.1111/j.1540-8175.2006.00281.x.
9
Heart failure: what does ejection fraction have to do with it?心力衰竭:射血分数与之有何关系?
J Cardiol. 2013 Jul;62(1):1-3. doi: 10.1016/j.jjcc.2013.02.017. Epub 2013 May 11.
10
Inflammatory pathways in patients with heart failure and preserved ejection fraction.射血分数保留的心力衰竭患者的炎症通路
Int J Cardiol. 2008 Sep 16;129(1):111-7. doi: 10.1016/j.ijcard.2007.05.061. Epub 2007 Jul 20.

引用本文的文献

1
Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.2 型糖尿病与射血分数中间值和保留的慢性心力衰竭:关注纤维化的血清生物标志物。
J Diabetes Res. 2020 Nov 7;2020:6976153. doi: 10.1155/2020/6976153. eCollection 2020.